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Purpose: Intrauterine lesions (IULs) are a common finding in women of reproductive age, 
particularly infertile women. Transvaginal sonography (TVS) is a popular tool for IUL detection, 
but there are conflicting data with respect to its accuracy.
Methods: Five hundred and six women were enrolled into the study. Of these, 496 underwent 
hysterosalpingography and subsequent TVS six different times during the course of their men-
strual cycle. If a lesion was detected, it was further evaluated by sonohysterography (SHG) and 
hysteroscopy.
Results: Of 496 women, 41 were shown to have IULs by TVS and those lesions were confirmed 
in 39 by SHG and hysteroscopy. All 39 lesions were detectable during the ovulatory and early 
luteal phase (days 16–19) of the menstrual cycle. Accuracy of TVS during different phases was 
largely dependent on the size of the lesion. TVS falsely detected two lesions and missed fine 
adhesions in two patients.
Conclusion: Accuracy of TVS in detection of IULs is highly dependent on the menstrual cycle 
phase, with the ovulatory and early luteal phase being the optimal time for this examination.
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Introduction
Structural pathologies in the uterine cavity are well-established as factors associated with 
infertility. Intrauterine lesions (IULs) have been linked generally to fertility   reduction 
and more specifically to implantation failure and miscarriage.1 The most commonly 
suspected intrauterine pathologies involved in infertility include endometrial polyps, 
shown to affect 9.4%–39.4% of infertile women,2,3 submucosal fibroids, adhesions, 
and uterine malformations. Efficient detection and adequate management of lesions 
is imperative in infertile women so optimal infertility treatment can proceed.
Hysterosalpingography (HSG) is a radiological modality most commonly used 
for the assessment of the uterine cavity. Although HSG is generally accepted as the 
initial diagnostic procedure performed in infertile women, several disadvantages are 
inherent to the technique,4 including exposure to ionizing radiation and the injection 
of radio-opaque material. Sonohysterography (SHG), described in detail elsewhere,5 
has rapidly become a popular tool for the diagnosis of intrauterine pathologies.6 In 
spite of its unequivocal advantages, such as low cost and the fact that patients are not 
subjected to ionizing radiation, the procedure is more time consuming than HSG and 
can lead to vasovagal shock in certain patients.5 SHG has yet to be presented as an 
alternative gold standard for investigating the uterine cavity.6
Hysteroscopy, however, is considered a gold-standard technique for uterine cavity 
examination, since it allows direct visualization of potential lesions and can be paired with International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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biopsy if necessary. Nevertheless, this procedure is invasive 
and often requires anesthesia and specialized equipment (ie, 
a hysteroscope). Moreover, hysteroscopy is more costly than 
HSG or SHG and does not provide information about the exter-
nal morphology of the organ,7 myometrium, or adnexa.8
Transvaginal sonography (TVS) is a simple, painless, 
and cost-effective examination that is capable of provid-
ing accurate information about IULs and is not associated 
with adverse pregnancy outcomes.9,10 However, studies of 
the diagnostic accuracy of TVS have produced conflicting 
results.10–16 Since specific disorders of the intrauterine cav-
ity are most efficiently diagnosed at different phases of the 
menstrual cycle,17 the conflicting results of previous reports 
may be at least partially due to this factor, in addition to 
interobserver bias. Uterine lesions could be the reason for 
infertility in 10% to 15% of cases.5
Identification of an efficient, accessible, painless, and 
reliable tool in the diagnosis of IULs is of great importance 
in the care of infertile patients, and the aim of the present 
study was to evaluate the diagnostic accuracy of TVS in 
the detection of intrauterine abnormalities during different 
phases of the menstrual cycle in infertile women. TVS was 
compared with SHG and hysteroscopy, which represent the 
gold standard in the evaluation of IULs.
Patients and methods
The study protocol was approved by the Institutional Review 
Board and Ethics Committee of the University of Medical 
Sciences in Urmia, Iran. Written informed consent was 
obtained from all participants in the presence of a witness. 
All patients were free to withdraw from the study at any time 
and for any reason.
Five hundred and six infertile females attending the Cen-
ter for Infertility Treatment and Research of Shahid Mottahari 
Hospital in Urmia, Iran, were consecutively enrolled in the 
study between September 2008 and February 2009. Patients’ 
infertility was defined as a failure to conceive after 1 year 
of unprotected intercourse.5 This center is the only infertility 
clinic in the West Azerbaijan province of Iran and all infertile 
patients in the area are referred exclusively to this center.
All participants initially underwent routine infertility 
work-up consisting of hormone testing (luteinizing hormone, 
follicle-stimulating hormone, prolactin, thyroid-stimulating 
hormone, estradiol), hysterosalpingography, and their 
  partner’s semen was analyzed. In addition, the couple’s etiol-
ogy of infertility and the regularity of the woman’s menstrual 
cycle were noted. Further participation in the study was 
dependent on the detection of IULs with HSG. Patients with 
no detectable IULs attempted assisted reproduction (AR) 
consisting of either intracytoplasmic sperm injection or 
intrauterine insemination. Women attempting AR and women 
with detected lesions underwent TVS every 3–4 days start-
ing from the first day of their menstrual cycle. In women 
attempting AR, TVS was used to evaluate the intrauterine 
cavity and to monitor follicular development and ovulation. 
In total, each patient underwent TVS six times. Phases of the 
menstrual cycle during which the lesion was visible or invis-
ible were recorded. If an intrauterine pathology was detected 
with TVS, the finding was explained to participants and those 
patients were then candidates to undergo SHG.
SHG was performed during the follicular phase, 2 days after 
the last menstrual period. Before the procedure was performed, 
all patients were examined by a gynecologist and by TVS to 
exclude the presence of fluid in the cul-de-sac (retrounterine 
pouch). The patients were also asked to refrain from intercourse 
before the examination. Pregnant patients, patients with sexu-
ally transmitted diseases, with fluid in the cul-de-sac, or with 
abnormal uterine bleeding were excluded from the study. 
If an IUL was confirmed with SHG, the patient underwent 
further hysteroscopy during which the lesion was resected.
TVS was performed by a physician with 10 years’ experi-
ence (MH); hysteroscopy was performed by another reproduc-
tion specialist with 12 years’ experience (FB); a   radiologist 
with 20 years’ experience, who had no   knowledge of the 
ultrasonographic results, performed SHG.
Results
Twelve of the 506 patients had IULs detectable by HSG 
and were referred for further treatment. These patients also 
underwent TVS every 3–4 days and TVS was able to detect 
the lesions in all cases. The remaining 492 patients attempted 
AR and also underwent TVS with the same frequency as 
patients with detected lesions, a total of six times. Of those, 
29 had TVS-detectable IULs, yielding a total of 41 women 
(12 + 29, 8%) with detectable IULs in the study.
The ages of the 41 women ranged from 19 to 42 years 
(mean age 31 years). Thirty-one (75%) suffered from primary 
and ten (25%) from secondary infertility. In 19 (46%) women, 
the infertility etiology was unknown; in twelve (29%) it was 
caused by a male factor, in five (12%) by anovulation and in 
another five by tubal factor. Thirty-two (78%) had regular 
menses and nine (22%) irregular.
The 41 patients with detectable IULs underwent SHG, 
which confirmed the lesions in 39 (95%) patients, and two 
(5%) showed false positive results (which were possibly due 
to blood clots). Of the 41 with detectable IULs, 39 had a 
  submucosal myoma and 35 had an intrauterine polyp (38 sin-
gle and only one double lesion). There were 35 polyps and International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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four submucosal leiomyomas. Lesions were mostly 5–10 mm 
in size but there were some up to 20 mm.
As a control, women with no detectable lesion on TVS 
were offered the option of undergoing SHG. Of 465 patients, 
122 consented and two of those were shown to have delicate 
adhesions previously undetected by TVS.
correlation between menstrual cycle  
and detection of IULs
All 39 SHG-confirmed lesions were detectable by TVS 
between days 16 and 19 of the menstrual cycle. Of those, nine 
were not detectable between days 20 and 24 and 20 were unde-
tectable between days 25 and 30, indicating that those lesions 
could not be visualized during the luteal phase of the cycle.
Nine of  the 39 lesions were ,1 cm in size and 30 
were $1 cm, as shown by hysteroscopy. Lesions of ,1 cm 
were detected by TVS during the ovulatory and luteal phases 
(days 16–19) of the cycle and none of those were detectable 
during the follicular phase (days 1–12). Only three of the 
lesions were detectable in the middle to late luteal phase 
(days 20–30).
All lesions $1 cm were detectable during the ovulatory 
and early luteal phases. Of those, 26 (67%) were visualized 
during the follicular phase and 27 (69%) were detected during 
the middle to late luteal phase. In summary, all 39 lesions 
were detected during the early luteal and ovulatory phases.
According to these data, the highest sensitivity, specific-
ity, positive predictive value (PPV), and negative predictive 
value (NPV) of TVS were at the beginning of the luteal phase 
(days 16–19), confirming this time segment as optimal for 
performing TVS (Table 1).
Discussion
IULs are a relatively common finding in women of reproduc-
tive age,1,18 and their occurrence is even more frequent in 
women who have trouble conceiving. As far as the authors 
are aware, this is the first study that has attempted to evaluate 
the diagnostic accuracy of TVS in diagnosing intrauterine 
pathologies in infertile women during different phases of 
their menstrual cycle.
The main finding of this study is that the efficiency of 
TVS is highly affected by the phase of the ovulatory cycle 
during which the procedure is performed. This was especially 
apparent in the diagnosis of lesions of ,1 cm, of which only 
one-third could be detected in the middle to late luteal phase, 
while all lesions were detectable in the ovulatory phase 
and at the beginning of the luteal phase. During the these 
parts of these two phases, all lesions $1 cm were detected, 
while only about 67%–69% of those were detected in other 
phases of the cycle. This indicates that the ovulatory phase 
and the beginning of the luteal phase are the optimal phases 
of the cycle to perform TVS to detect intrauterine patholo-
gies. TVS sensitivity, specificity, PPV , and NPV during this 
phase (days 16–19), in comparison with SHG, reached 95%, 
98%, 95.1%, and 98%, respectively (Table 2).
There are discordant reports of the sensitivity and specific-
ity of TVS in the diagnosis of intrauterine pathologies6,13,15,19–23 
(Table 3, Figure 1), while there are no such major discrep-
ancies in the evaluation of SHG or hysteroscopy. Since the 
authors’ results clearly indicate that menstrual cycle phase 
may be an important factor in the efficiency of TVS, previ-
ous conflicting reports may be due to the fact that TVS is 
performed on various days of the ovulatory cycle, while hys-
teroscopy and SHG are predominantly performed during the 
early follicular phase because menstrual bleeding decreases 
visualization of the uterine cavity and because they cannot 
be performed during the luteal phase since those procedures 
may interfere with ongoing pregnancy and lead to miscar-
riage or ectopic   pregnancy. TVS, however, can be performed 
at any time without increased danger to the patient or to a 
potential embryo.
Since the sensitivity, specificity, PPV , and NPV of HSG 
compared with SHG was 29%, 98%, 100%, and 78%, 
Table 1 Sensitivity, specificity, positive predictive values (PPVs), 
and negative predictive values (nPVs) of transvaginal sonography 
on different days of the menstrual cycle
Day of  
cycle
N Yes* Sensitivity Specificity PPV NPV
1–4 495 11 28.2% 100% 100% 94%
5–8 490 16 41.2% 100% 100% 95%
9–12 480 26 66.6% 100% 100% 97%
13–15 471 35 89.7% 100% 100% 99%
16–19 467 39 100% 100% 100% 100%
20–24 476 30 76.9% 100% 100% 98%
25–30 487 19 48% 100% 100% 95.8%
Note: *refers to the number on transvaginal sonography, on which the lesions were 
seen.
Abbreviation: n, number.
Table 2 Sensitivity, specificity, positive predictive values (PPVs), 
and negative predictive values (nPVs) of transvaginal sonography 
compared with sonohysterography
Day of cycle Sensitivity Specificity PPV NPV
1–4 26.8% 98% 84.6% 80%
5–8 39% 98% 88.8% 82.7%
9–12 63% 98% 92.8% 88.8%
13–15 85.3% 98% 94.5% 95.2%
16–19 95% 98% 95% 98.2%
20–24 73.1% 98% 93.7% 91.6%
25–30 46.3% 98% 90.4% 84.5%International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Figure 1 Heat map of outcomes of various studies assessing transvaginal sonography (complementary to Table 3*). 
Note: *rows 1–10 correlate with studies 1–10 in Table 3.
Abbreviations: PPV, positive predictive value; nPV, negative predictive value. 
Table 3 Sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) of transvaginal sonography 
(TVs) in different studies (complementary to Figure 1*)
Study Time TVS performed Sensitivity Specificity PPV NPV
  1. shalev and Dicker13 Day 9–13 100% 96.3% 91.3% 100%
  2. Dueholm et al22 Without relationship  
to phase of cycle
69% 83% 71% 82%
  3. guven et al20 Without relationship  
to phase of cycle
78% 38% 61% 59%
  4. Alborzi et al19 Without relationship  
to phase of cycle
72% 92% 94% 65%
  5. Kelekci et al21 early proliferative phase 56.2% 72% 56.3% 72%
  6. Loverro et al15 Day 6–10 84.5% 98.7% 98% 89.2%
  7. Valentin23 Without relationship  
to phase of cycle
69% 83% 71% 82%
  8. grimbizis et al24 Without relationship  
to phase of cycle
44.8% 77.5% – –
  9. Present study Day 16–19 95% 98% 95.1% 98%
10. shalev et al25 Follicular phase 71.4% 100% 100% 97.1%
Note: *studies 1–10 correlate with rows 1–10 in Figure 1.
  respectively, it suggests that HSG is a very limited method 
for the diagnosis of IULs, as previously reported.8 If fallopian 
tubes patency does not need to be assessed, the authors sug-
gest TVS as the first method to assess the intrauterine cavity, 
although it may not be able to detect smaller pathological 
structures.
Delicate adhesions in two patients were not detected by 
TVS but were shown by SHG. However, using TVS with 
saline infusion has been shown to reach the sensitivity of 
hysteroscopy in the diagnosis of IULs.23 If hysteroscopy is 
inaccessible, performing TVS at the ovulatory or early luteal 
phase, in combination with SHG, may be an optimal approach International Journal of Women’s Health
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for evaluating the integrity of intrauterine cavity. Unlike 
hysteroscopy, SHG provides additional information about the 
adnexa and the combined techniques provide invaluable data 
about the reproductive system of infertile females.
In conclusion, the data indicate that the accuracy of TVS 
in the diagnosis of IULs is highly dependent on the ovulatory 
cycle phase and, if performed during the early luteal phase, 
its specificity reaches 98%. The authors’ results indicate 
that the optimal time to perform TVS to detect intrauterine 
pathologies is during the ovulatory or early luteal phases. All 
lesions, irrespective of their size, were detected during this 
cycle phase (ovulatory or early luteal phases, days 16–19).
In addition, if confirmed by further studies, TVS accom-
panied by SHG, when performed at the optimal ovulatory 
cycle phase, may represent a future cost-effective alternative 
to hysteroscopy in the evaluation of the intrauterine cavity.
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